36 research outputs found
The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage
Background and Purpose
There are no generally accepted criteria for the etiologic classification of intracerebral hemorrhage
(ICH). For this reason, we have developed a set of etiologic criteria and have
applied them to a large number of patients to determine their utility.
Methods
The H-ATOMIC classification includes 7 etiologic categories: Hypertension, cerebral Amyloid
angiopathy, Tumour, Oral anticoagulants, vascular Malformation, Infrequent causes
and Cryptogenic. For each category, the etiology is scored with three degrees of certainty:
Possible(3), Probable(2) and Definite(1). Our aim was to perform a basic study consisting of
neuroimaging, blood tests, and CT-angio when a numerical score (SICH) suggested an
underlying structural abnormality. Combinations of >1 etiologic category for an individual
patient were acceptable. The criteria were evaluated in a multicenter and prospective study
of consecutive patients with spontaneous ICH.
Results
Our study included 439 patients (age 70.8 ± 14.5 years; 61.3% were men). A definite etiology
was achieved in 176 (40.1% of the patients: Hypertension 28.2%, cerebral Amyloid
angiopathy 0.2%, Tumour 0.2%, Oral anticoagulants 2.2%, vascular Malformation 4.5%,
Infrequent causes 4.5%). A total of 7 patients (1.6%) were cryptogenic. In the remaining
58.3% of the patients, ICH was attributable to a single (n = 56, 12.7%) or the combination of
2 (n = 200, 45.5%) possible/probable etiologies. The most frequent combinations of etiologies
involved possible hypertension with possible CAA (H3A3, n = 38) or with probable CAA
(H3A2, n = 29), and probable hypertension with probable OA (H2O2, n = 27). The most frequent category with any degree of certainty was hypertension (H1+2+3 = 80.6%) followed
by cerebral amyloid angiopathy (A1+2+3 = 30.9%).
Conclusions
According to our etiologic criteria, only about 40% patients received a definite diagnosis,
while in the remaining patients ICH was attributable to a single possible/probable etiology or
to more than one possible/probable etiology. The use of these criteria would likely help in
the management of patients with ICH.This work was supported by Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes temáticas de Investigación Cooperativa) INVICTUS RD012/0014 (JM-F, PC-R, AM-D, LP-S, RD-M), FEDER (Fondo Europeo de Desarrollo Regional)
Granulocytes-Rich Thrombi in Cerebral Large Vessel Occlusion Are Associated with Increased Stiffness and Poorer Revascularization Outcomes
Altres ajuts: acords transformatius de la UABWe aim to identify a profile of intracranial thrombus resistant to recanalization by mechanical thrombectomy (MT) in acute stroke treatment. The first extracted clot of each MT was analyzed by flow cytometry obtaining the composition of the main leukocyte populations: granulocytes, monocytes, and lymphocytes. Demographics, reperfusion treatment, and grade of recanalization were registered. MT failure (MTF) was defined as final thrombolysis in cerebral infarction score IIa or lower and/or need of permanent intracranial stenting as a rescue therapy. To explore the relationship between stiffness of intracranial clots and cellular composition, unconfined compression tests were performed in other cohorts of cases. Thrombi obtained in 225 patients were analyzed. MTF were observed in 30 cases (13%). MTF was associated with atherosclerosis etiology (33.3% vs. 15.9%; p = 0.021) and higher number of passes (3 vs. 2; p < 0.001). Clot analysis of MTF showed higher percentage of granulocytes [82.46 vs. 68.90% p < 0.001] and lower percentage of monocytes [9.18% vs.17.34%, p < 0.001] in comparison to successful MT cases. The proportion of clot granulocytes (aOR 1.07; 95% CI 1.01-1.14) remained an independent marker of MTF. Among thirty-eight clots mechanically tested, there was a positive correlation between granulocyte proportion and thrombi stiffness (Pearson's r = 0.35, p = 0.032), with a median clot stiffness of 30.2 (IQR, 18.9-42.7) kPa. Granulocytes-rich thrombi are harder to capture by mechanical thrombectomy due to increased stiffness, so a proportion of intracranial granulocytes might be useful to guide personalized endovascular procedures in acute stroke treatment. Supplementary Information: The online version contains supplementary material available at 10.1007/s13311-023-01385-1
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers
Despite advances in understanding the biology of mature T and natural killer (NK)/T cell neoplasia, current therapies, even the most innovative ones, are still far from ensuring its cure. The only treatment to date that has been shown to control aggressive T cell neoplasms in the long term is allogeneic stem cell transplantation (alloSCT). We aim to report the results of alloSCT for advanced mature T and NK/T neoplasias performed in centers from our national GELTAMO/GETH (Grupo Español de Linfoma y Trasplante de Médula Ósea/Grupo Español de Trasplante Hematopoyético y Terapia Celular) over the past 25 years. As a secondary objective, we analyzed the results of alloSCT from haploidentical donors. We performed a retrospective analysis of all patients who received an alloSCT in Spanish centers (n = 201) from September 1995 to August 2018. The 2-year overall survival (OS) and disease-free survival (DFS) were 65.5% and 58.2%, respectively. The univariate for OS and DFS showed statistically different hazard ratios for conditioning intensity, response pre-alloSCT, comorbidity index, donor/receptor cytomegalovirus status and Eastern Cooperative Oncology Group (ECOG) pre-alloSCT, but only a better ECOG pre-alloSCT remained significant in the multivariate analysis. There was an increased incidence of relapse in those patients who did not develop chronic graft-versus-host disease (GVHD) and an increased risk of death in those developing moderate to severe acute GVHD. The 1-year nonrelapse mortality was 21.9% and was mainly due to GVHD (30%) and bacterial infections (17%). When comparing unrelated donors with haploidentical donors, we found similar results in terms of OS and DFS. There was, however, a reduction of acute GVHD in the haploidentical group (P = .04) and trend to a reduction of chronic GVHD. In conclusion, alloSCT is the only curative option for most aggressive T cell neoplasias. Haploidentical donors offer similar results to related donors in terms of survival with a reduction of acute GVHD
Rapport ESBL-Attributieanalyse (ESBLAT) : Op zoek naar de bronnen van antibioticaresistentie bij de mens
Samenvatting ESBL-Attributieanalyse (ESBLAT) : Op zoek naar de bronnen van antibioticaresistentie bij de mens
Samenvatting over een project rondom ESBL's. Doelstellingen waren: vaststellen wat de bijdrage is van alle ESBL-reservoirs aan het dragerschap en infecties bij mensen en vaststellen wat de transmissieroutes zijn vanuit deze reservoirs naar de (geïnfecteerde) mens
Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
Acute myocardial infarction causes lethal injury to cardiomyocytes during both ischaemia and reperfusion (IR). It is important to define the precise mechanisms by which they die in order to develop strategies to protect the heart from IR injury. Necrosis is known to play a major role in myocardial IR injury. There is also evidence for significant myocardial death by other pathways such as apoptosis, although this has been challenged. Mitochondria play a central role in both of these pathways of cell death, as either a causal mechanism is the case of mitochondrial permeability transition leading to necrosis, or as part of the signalling pathway in mitochondrial cytochrome c release and apoptosis. Autophagy may impact this process by removing dysfunctional proteins or even entire mitochondria through a process called mitophagy. More recently, roles for other programmed mechanisms of cell death such as necroptosis and pyroptosis have been described, and inhibitors of these pathways have been shown to be cardioprotective. In this review, we discuss both mitochondrial and mitochondrial‐independent pathways of the major modes of cell death, their role in IR injury and their potential to be targeted as part of a cardioprotective strategy. This article is part of a special Issue entitled ‘Mitochondria as targets of acute cardioprotection’ and emerged as part of the discussions of the European Union (EU)‐CARDIOPROTECTION Cooperation in Science and Technology (COST) Action, CA16225
Antimicrobial resistance in aquaculture : A global analysis of literature and national action plans
Since the establishment of a Global Action Plan (GAP) on Antimicrobial Resistance (AMR) (68th World Health Assembly, Geneva, Switzerland, 2015), most members of the World Health Organisation (WHO) have developed and implemented a National Action Plan (NAP) based on a "One Health" approach to AMR. Aquaculture, significant among the food producing sectors, has often been overlooked in AMR governance. We did a systematic review of 95 country NAPs and assessed the inclusion of aquaculture. We also reviewed the scientific literature from 1996 until April 2021 to retrieve data characterising AMR in aquaculture during the last 25 years. In our analysis, 37% of countries did not mention an aquaculture component within their AMR NAP. The South-East Asia Region had the highest implementation rate of AMR-aquaculture programmes. Our literature review indicated that most AMR-aquaculture related studies have taken place in China, followed by the United States of America and India. Beta-lactamases, tetracyclines, sulfonamides, macrolides, and fluoroquinolones were the most represented classes of antibiotics, with Vibrio spp. and Aeromonas spp. as the most investigated antimicrobial-resistant bacteria. This review highlighted the gaps in AMR-aquaculture governance and the progress made across WHO members. Countries are encouraged to (i) fulfil their commitments by developing and/or fully implementing the AMR NAP, (ii) further engage in the research, monitoring, and surveillance of antimicrobial usage and AMR within the aquaculture sector, and (iii) collaborate at national and international level for a concerted "One Health" approach